Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,602 public trials 545 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

NCT07249528

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent Only) Commack, New York, United States
View Trial Details
Recruiting

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

NCT07477587

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • D&H National Research Center Margate, Florida, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 81 locations
View Trial Details
Recruiting

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

NCT07409246

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center /ID# 280273 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067 Irvine, California, United States
  • Colorado Blood Cancer Institute /ID# 280275 Denver, Colorado, United States
  • City Of Hope - Atlanta. /ID# 280294 Newnan, Georgia, United States
View Trial Details
Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

NCT06433947

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Emory Winchip Cancer Center Atlanta, Georgia, United States
View Trial Details
Recruiting

Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma

NCT05853965

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University Medical Center Hamburg-Eppendorf Hamburg, Ham, Germany
  • Klinikum Chemnitz Chemnitz, Germany
  • Uniklinik Heidelberg Heidelberg, Germany
  • UKSH Lübeck Lübeck, Germany
View Trial Details

Related conditions